Safety, Tolerability, and Effectiveness of Rasagiline Mesylate in Patients With Parkinson's Disease
Clinical trial NCT00203138 · COMPLETED
Trial details
- NCT number
- NCT00203138
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-06-01
- Primary completion
- 2006-11-01
- Enrollment
- 306
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.